Ginkgo biloba for memory problems after a mild stroke
Part of Brain & nervous system, Heart & circulation, Mental health clinical trials.
This trial tests whether adding ginkgo biloba extract tablets to standard stroke care helps improve memory and thinking in people who had a mild stroke. You may join if you are 55 or older, had a mild stroke in the last 1 to 2 weeks, and now have some cognitive difficulties.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 55 years or older.
- You had a mild stroke (not disabling) 7 to 14 days ago, confirmed with an MRI.
- You have some memory or thinking problems after the stroke.
- You can speak and understand Chinese for the study assessments.
- You did not have dementia or serious memory loss before the stroke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a ginkgo biloba extract supplement can help improve thinking and memory after a stroke. It is for people who recently had a stroke and have some mild to moderate memory problems, but are not already taking other memory medications.
This trial tests whether a natural extract from ginkgo biloba can help people with mild memory or thinking problems caused by small vessel disease in the brain. It looks for adults aged 50 to 75 who have had these symptoms for at least 3 months but can still live independently.
This trial tests whether a specific ginkgo biloba extract (EGb761) can improve thinking and memory in people with mild cognitive impairment (MCI). It also looks at changes in blood markers related to the condition.
This study tests whether Ginkgo biloba extract can improve blood markers and cognitive function in people with mild cognitive impairment (early memory loss). Researchers will measure changes in blood biomarkers to understand how Ginkgo may help protect brain health.
This trial tests if a specific ginkgo-based medicine (Ginkgo Diterpene Lactone Meglumine) can help people who had an ischemic stroke within the last 48 hours. It looks at whether taking this drug improves recovery compared to standard care.
This trial tests whether a combination of cilostazol (a blood flow medication) and ginkgo (a herbal supplement) can help protect memory and thinking skills in people over 60 with type 2 diabetes. You may join if your memory is slightly below normal but not severely impaired.
Hear when a new Ischemic Stroke Hospitalized trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.